This site is intended for the use of investors in Ireland only. Please read and accept the following disclaimer:
Approved and available for sale in Ireland are the following funds:
Kames High Yield Global Bond Fund
Kames Investment Grade Global Bond Fund
Kames Strategic Global Bond Fund
Kames Absolute Return Bond Fund
Kames Global Equity Income Fund
Kames Equity Market Neutral Fund
Kames Equity Market Neutral Plus Fund
Kames Absolute Return Bond Global Fund
Kames Absolute Return Bond Constrained Fund
Kames Emerging Market Bond Fund
Kames Global Sustainable
Diversified Income Fund
Kames Global Diversified Growth Fund
Kames Global Equity Market Neutral Fund
This website does not constitute an offer or solicitation to buy any of the funds mentioned, for any of the following reasons:
- if you are in a jurisdiction where this would be unlawful
- if the person making an offer is not qualified
- if it is unlawful to make an offer to a certain type of investor.
Our funds are not available for distribution to or investment by US investors. The funds are not registered under the United States Securities Act of 1933 or the United States Investment Company Act of 1940. Therefore, we cannot directly or indirectly offer or sell them:
- in the US
- in any of its states, territories, or possessions
- in other areas subject to the US’s jurisdiction
- to a US individual
The information on this site has been issued and approved by Kames Capital. It does not constitute investment, tax, legal or other advice. The site content may change from time to time. Please ensure you rely on the latest literature.
RISK WARNINGS - Please refer to the Full Prospectus and Key Investor Information documents.
Please note the following risk warnings:
• The past performance of an investment is not a guide to future performance.
• The value of investments, and the income from them, may go down as well as up and is not guaranteed so an investor may not get back the amount originally invested. Any tax reliefs mentioned are those currently available and are subject to change.
• If the funds hold securities denominated in a currency other than sterling, changes in exchange rates may affect the value of your investment.
• Where charges are taken wholly or partly out of a fund's capital, distributable income will be increased at the expense of capital which will either be eroded or future growth constrained.
• Any investment objective, performance benchmark and yield information will be treated as a target only and should not be considered as an assurance or guarantee of the performance of the fund or any part of it.
Investment in the securities of smaller and unquoted companies can involve greater risk than is customarily associated with investment in larger, more established companies. In particular, smaller companies often have limited product lines, markets or financial resources and may be dependent for their management on a smaller number of key individuals. In addition, the market for securities in smaller companies is often less liquid than that for securities in larger companies, bringing with it potential difficulties in acquiring, valuing and disposing of such securities. Proper information for determining their value or the risks to which they are exposed may also not be available.
Some funds will often carry greater risks in return for higher potential rewards. Specialist funds, which invest in specialist markets or small sectors of industry, are likely to carry higher risks than most general funds. Investment in technology related stocks can be more volatile than investment in more established companies. Above average price movements can be expected.
Market Risk: The potential for change in market value of instruments due to adverse movements in equity, bond, commodity, currency and other market prices, indices or interest rates or changes in the anticipated or calculated volatility of these movements.
Liquidity Risk: This includes both market liquidity risk and funding risk. Market liquidity risk is the inability to trade an instrument at the desired price due to a lack of supply or market demand. Funding risk is where a fund has insufficient cash to meets its financial obligations.
Counterparty Risk: The risk that the failure of a counterparty to meet its obligations leads to a financial loss to the fund, both through loss of any monies owed to the fund by the counterparty and the cost of reinstating economic exposure in the case of counterparty default.
Concentration Risk: The risk of a portfolio being too concentrated in particular positions or too exposed to certain issuers. Highly concentrated positions can exacerbate market, liquidity and counterparty risk.
Absolute Return Funds: While the investment objective of absolute return funds is to achieve a positive return in all market conditions, this is not guaranteed in any way. Investment professionals must ensure that they meet their obligations in relation to their understanding of this product and the risks involved, and the extent to which this product meets the needs of their clients.
As a result of money laundering regulations, we may request additional proof of identification. Further details are in our prospectuses and other constitutional documents.
Investors should only invest in our funds on the basis of the relevant offer document; this means the prospectus, Key Investor Information document or other applicable terms and conditions.
These documents are freely available by calling our investor helpdesk on + 353 1 622 4493 or in writing from Citigroup Europe plc, PO Box 11167, Cardiff Lane, Dublin 2, Ireland.
Kames Capital does not warrant the accuracy, adequacy or completeness of the information and materials contained on this website and expressly disclaims liability for errors or omissions in such information and materials.
For Professional Investors and those investing on behalf of an underlying investor only:
We will treat you as an investor who generally invests on behalf of underling clients. It is your responsibility to provide the most recent Key Investor Information (KII) to the underlying client for each investment you make on their behalf. If you invest on your own behalf, you should ensure you access and review the KII, or request that we send it to you, before investing. By placing any future investment with us, you will be taken to have agreed to this approach to provision of our KII. All of our up-to-date KII are available from www.kamescapital.com.
Kames Capital Investment Company Ireland is a UCITS collective investment scheme registered in the Republic of Ireland regulated by the Central Bank of Ireland. A limited range of Kames Capital VCIC sub-funds and share class have “Reporting Fund” status. The Company seeks to comply with UK Reporting Fund status requirements; more information is contained in the full prospectus.
Legal Information – www.kamescapital.com/legal.aspx